EUR 11.94
(5.29%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 60.43 Million EUR | 25.64% |
2022 | 48.1 Million EUR | 39.24% |
2021 | 34.54 Million EUR | 0.91% |
2020 | 34.23 Million EUR | 122.67% |
2019 | 15.37 Million EUR | 15.81% |
2018 | 13.27 Million EUR | 34.21% |
2017 | 9.89 Million EUR | 49.75% |
2016 | 6.6 Million EUR | 285.57% |
2015 | 1.71 Million EUR | 0.0% |
2014 | - EUR | 0.0% |
2013 | - EUR | 0.0% |
2012 | - EUR | -100.0% |
2011 | 3121.39 EUR | -99.14% |
2010 | 362.77 Thousand EUR | 0.0% |
2009 | - EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 95.4 Million EUR | 61.36% |
2024 Q1 | 59.12 Million EUR | -2.17% |
2023 Q2 | 99.47 Million EUR | 57.22% |
2023 Q3 | 71 Million EUR | -28.62% |
2023 FY | 60.43 Million EUR | 25.64% |
2023 Q4 | 60.43 Million EUR | -14.89% |
2023 Q1 | 63.26 Million EUR | 31.53% |
2022 Q4 | 48.1 Million EUR | -8.7% |
2022 Q2 | 72.19 Million EUR | 37.8% |
2022 FY | 48.1 Million EUR | 39.24% |
2022 Q1 | 52.39 Million EUR | 51.65% |
2022 Q3 | 52.68 Million EUR | -27.03% |
2021 Q1 | 46.55 Million EUR | 35.98% |
2021 Q3 | 35.81 Million EUR | -20.51% |
2021 Q4 | 34.54 Million EUR | -3.53% |
2021 FY | 34.54 Million EUR | 0.91% |
2021 Q2 | 45.05 Million EUR | -3.22% |
2020 Q1 | - EUR | -100.0% |
2020 FY | 34.23 Million EUR | 122.67% |
2020 Q4 | 34.23 Million EUR | 6.77% |
2020 Q3 | 32.06 Million EUR | 57.59% |
2020 Q2 | 20.34 Million EUR | 0.0% |
2019 Q4 | 15.37 Million EUR | 0.0% |
2019 FY | 15.37 Million EUR | 15.81% |
2019 Q2 | 13.16 Million EUR | 0.0% |
2019 Q1 | - EUR | -100.0% |
2018 Q1 | 13.09 Million EUR | 32.38% |
2018 FY | 13.27 Million EUR | 34.21% |
2018 Q4 | 13.27 Million EUR | -4.86% |
2018 Q3 | 13.95 Million EUR | 6.56% |
2018 Q2 | 13.09 Million EUR | 0.0% |
2017 Q4 | 9.89 Million EUR | -6.61% |
2017 Q3 | 10.59 Million EUR | 30.39% |
2017 Q2 | 8.12 Million EUR | 0.0% |
2017 Q1 | 8.12 Million EUR | 22.98% |
2017 FY | 9.89 Million EUR | 49.75% |
2016 Q2 | - EUR | 0.0% |
2016 Q1 | - EUR | -100.0% |
2016 FY | 6.6 Million EUR | 285.57% |
2016 Q4 | 6.6 Million EUR | 0.0% |
2016 Q3 | 6.6 Million EUR | 0.0% |
2015 Q4 | 1.71 Million EUR | 0.0% |
2015 FY | 1.71 Million EUR | 0.0% |
2015 Q2 | - EUR | 0.0% |
2014 Q4 | 901.04 Thousand EUR | 0.0% |
2014 FY | - EUR | 0.0% |
2014 Q2 | - EUR | 0.0% |
2013 Q2 | - EUR | 0.0% |
2013 Q4 | - EUR | 0.0% |
2013 FY | - EUR | 0.0% |
2012 Q2 | 3000.00 EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | - EUR | -100.0% |
2011 FY | 3121.39 EUR | -99.14% |
2011 Q4 | 3121.39 EUR | 0.0% |
2011 Q2 | 535 Thousand EUR | 0.0% |
2010 Q4 | 362.77 Thousand EUR | 0.0% |
2010 FY | 362.77 Thousand EUR | 0.0% |
2010 Q2 | 358 Thousand EUR | 0.0% |
2009 Q4 | - EUR | 0.0% |
2009 FY | - EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cegedim SA | 9.2 Million EUR | -556.853% |
Guerbet SA | 305.17 Million EUR | 80.196% |
Nexus AG | 3.22 Million EUR | -1772.854% |
Bastide Le Confort Médical SA | 43.2 Million EUR | -39.878% |
Revenio Group Oyj | 10.5 Million EUR | -475.59% |
Drägerwerk AG & Co. KGaA | 657.88 Million EUR | 90.813% |
Sartorius Aktiengesellschaft | 1.03 Billion EUR | 94.17% |
LNA Santé SA | 148.29 Million EUR | 59.246% |
Siemens Healthineers AG | 4.26 Billion EUR | 98.582% |
Equasens Société anonyme | 10.31 Million EUR | -485.971% |
Stratec SE | 142.62 Million EUR | 57.625% |